Clinical Trials Browser

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT06846346 2025-11-28

GRACIE

Phase 2 Recruiting

88 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT03777813 2025-11-18

ARION

Phase 2 Completed

112 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT04363801 2025-10-09

DisTinGuish

Phase 2 Terminated

247 enrolled 38 charts

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT07018570 2025-08-26

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

Phase 2 Recruiting

26 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT04864067 2025-07-01

NOAHS-ARC

Phase 2 Active not recruiting

73 enrolled

Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT01726582 2023-08-14

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

Phase 2 Completed

229 enrolled 14 charts

Gastrointestinal

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT01660711 2021-11-08

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

Phase 2 Completed

22 enrolled 8 charts

Tumor-Agnostic

Adenocarcinoma, Neoplasms

NCT01442935 2021-06-18

Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

Phase 2 Completed

256 enrolled

Gastrointestinal

Adenocarcinoma, Colorectal Neoplasms

NCT01652976 2021-01-05

FOLFOX-D

Phase 2 Completed

44 enrolled 18 charts

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT00515411 2019-12-10

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Phase 2 Completed

111 enrolled 11 charts

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT01504256 2018-01-23

CatuNeo

Phase 2 Completed

42 enrolled

Gynecologic

Adenocarcinoma, Peritoneal Neoplasms

NCT01472029 2017-06-19

HerFLOT

Phase 2 Completed

53 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT01932580 2015-10-27

Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma

Phase 2 Completed

10 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma

NCT01554059 2014-11-10

New Beat

Phase 2 Completed

25 enrolled

Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT01175291 2011-12-05

FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT00054873 2006-07-11

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

Clinical Trials

DG-03

GRACIE

ARION

DisTinGuish

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

NOAHS-ARC

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

FOLFOX-D

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

CatuNeo

HerFLOT

Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma

New Beat

FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer